Oxygen Concentrator Market Size, Share, and Industry Analysis By Product (Fixed and Portable), By Technology (Continuous Flow and Plus Flow), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, Respiratory Distress, Sleep Apnea, and Others), By End User (Hospitals & Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

The global oxygen concentrator market size was valued at USD 1.29 billion in 2025. The market is projected to grow from USD 1.37 billion in 2026 to USD 2.22 billion by 2034, exhibiting a CAGR of 6.21% during the forecast period.

The global oxygen concentrator market is expanding as people are now using oxygen concentrators at home more often because they need at-home treatment and ageing populations require telemedicine support to monitor patient health effectively. An oxygen concentrator helps patients with respiratory conditions such as COPD experience better breathing. This device sends extra oxygen through a medical therapy.

• According to PubMed Central, the global market for medical oxygen concentrators was valued at USD 1.75 billion in 2018.
• As per PubMed Central, the prices of new home oxygen concentrators range from USD 595 to USD 2,000, depending on features and accessories.

Populations in all nations need ready access to oxygen therapy because respiratory diseases keep increasing due to air pollution and new COVID-19 infections.

Oxygen Concentrator Market Driver

Rising Diagnoses of Medical Conditions to Expand the Market

The oxygen concentrator market receives strong support from rising diagnoses of medical conditions, namely COPD, asthma, and pulmonary fibrosis. The growing number of pollution particles in urban environments makes it easier for respiratory problems to begin and grow worse.

Number of Ageing Adults to Advance the Market

The number of ageing adults is increasing the demand for oxygen concentrators. Through time, older adults naturally develop respiratory weakness, making them vulnerable to health problems. As people age, they commonly develop several illnesses that impair their breathing capacity, especially heart disease and diabetes.

Oxygen Concentrator Market Restraint

High Price of Oxygen Concentrators to Pose Potential Impediments on this Market

The high price of oxygen concentrators limits market expansion because they become too expensive for people to afford. Even though the latest oxygen concentrators are more portable and functional, they cost too much money for most people living in poor regions or without proper medical benefits.

Oxygen Concentrator Market Opportunity

Home-Based Oxygen Therapy to Create Opportunity in this Market

Expanding home-based oxygen therapy needs creates a major business potential for oxygen concentrator sellers. The market growth in oxygen concentrators results from multiple driving forces, including more older adults, greater chronic respiratory cases, and rising patient-centred care demand. Sharing medical treatments at home delivers better patient satisfaction while trimming medical spending and helps patients handle life solo.

Key Insights

The report covers the following key insights:

• Market drivers, restraints and opportunities
• Influence of key industrial players and key developments
• Healthcare expenditure
• Research and development

Segmentation

Analysis by Product

By product, the oxygen concentrator market is divided into fixed & portable.

Home and healthcare facilities require fixed oxygen concentrators, which operate as durable stationary units because they deliver strong oxygen flow. Chronic respiratory patients and home care patients keep pushing up market growth for fixed units.

Oxygen concentrators designed for mobility have a small size and lightweight that help people move freely. Users are more focused on portable therapy systems because they want better patient mobility and want to learn about active oxygen treatment benefits.

Analysis by Technology

Based on technology, the market is divided into continuous flow & plus flow.

Continuous flow oxygen concentrators release fixed amounts of oxygen, which the patient receives uninterrupted even while breathing at different rates. The medical sector requires continuous flow oxygen therapy to properly treat advanced respiratory patients at home and in clinics, leading to steady segment growth.

Pulse flow oxygen concentrators save oxygen supply because they give oxygen during patient inhalation while maintaining battery power in portable units. The part of our business that supplies pulse flow elements grows quickly because patients need lightweight portable oxygen options that keep them independent.

Analysis by Application

Based on application, the market is divided into chronic obstructive pulmonary disorder (copd), asthma, respiratory distress, sleep apnea, and others.

The growth of the oxygen therapy segment depends heavily on COPD diagnosis and treatment learning because doctors now use oxygen medicine more for patient management and stopping disease progression.

The asthma patient base helps the oxygen concentrator market grow even though it enters the market through distinct purposes. The higher number of people suffering from severe asthma in polluted urban areas creates strong demand for both medical and home oxygen concentrators.

Analysis by End User

Based on end user, the market is divided into hospitals & clinics, homecare settings, and others

Hospitals and clinics need more oxygen concentrators to help their growing patient population with respiratory problems. These institutions demand more equipment because seniors, chronic disease sufferers, and persons exposed to infectious diseases need breathing machine support.

The rise of oxygen concentrators depends greatly on homecare facilities. Oxygen concentrators designed for portability and user comfort have strong demand in home-based patient care because they enable individuals to stay active in their daily lives.

 Regional Analysis

Based on region, the oxygen concentrator market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America leads the oxygen concentrator market because its top medical care system receives high healthcare payments to treat many respiratory patients. Research and development activities throughout the area result in introducing state-of-the-art medical technology. The market grows because healthcare services are now delivered at home and because the government pays for treatment. The number of patients diagnosed with COPD, asthma, sleep apnoea, and ageing; more people drive up oxygen concentrator usage rates.

As oxygen concentrators increase, this equipment market in Europe keeps surging from people's ageing and more chronic respiratory condition cases. Oxygen concentrator business growth in Europe rises from nations with advanced healthcare systems such as Germany, the U.K., and France because of their friendly reimbursement rules. The community demands high-quality safety measures in their medical devices, which leads them to choose top-quality oxygen concentrators. As more people become aware of respiratory health issues, more customers choose home healthcare, which pushes European market growth.

The Asia Pacific markets are expanding at the fastest rate in the oxygen concentrator sector. These factors below are driving the market's increased demand in this region. They include older citizens, rising respiratory health problems, and higher health care costs. The oxygen concentrator market grows faster because both China and India supply significant demand due to their large populations and ongoing healthcare knowledge increase. Air pollution increases across Asia while more patients choose medical care at home, which both boost oxygen concentrator sales in the region. Manufacturing activities are expanding within the area to cut production costs through local factories.

Key Players Covered

The report includes the profiles of the following key players:

• Philips N.V. (U.S.)
• Chart Industries (U.S.)
• Inogen, Inc. (U.S.)
• Drive Devilbiss International (U.S.)
• Supera Anesthesia Innovations (Oregon)
• GCE (Switzerland)
• TEIJIN LIMITED (Japan)
• DAIKIN INDUSTRIES, Ltd. (Japan)
• BPL Medical Technologies (India)
• O2 Concepts, LLC. (U.S.)

Key Industry Developments

• In February 2025, Inogen, Inc. entered a corporate partnership to help more people access portable oxygen therapy through a major healthcare provider. The healthcare company and Inogen formed a relationship to put Inogen's advanced oxygen technology into patient care programs across the organisation.
• In March 2024, a U.S. Congressman brought forward the Supplemental Oxygen Access Reform (SOAR) Act to enhance laws that control how people with respiratory issues receive supplemental oxygen. This law worked to resolve oxygen therapy payment issues for both providers and patients, especially the elderly receiving their health insurance through Medicare.
• In October 2022, O2 Concepts launched the Oxlife Liberty development to improve portable oxygen therapy technology. The launch delivered a product that helps patients move freely and be independent through its small and lightweight portable oxygen unit. The Oxlife Liberty supplies oxygen more effectively with increased battery time to meet the exercise needs of people who need supplemental oxygen.